Mendelian Randomization and Infection: Pitfalls and Promises
The Journal of Infectious Diseases · 15.09.2025 · 232 (3) · 525-533
DOI: 10.1093/infdis/jiaf251 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 28.05.2025. Verfasst von Fergus Hamilton und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Communicable Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Medical Research Council.
Abstract (Originalsprache)
Mendelian randomization (MR) is an increasingly common study design in infectious diseases (ID). It holds promise for identifying causes and consequences of infections where conventional epidemiology has struggled, and can highlight plausible drug targets, as shown in successful coronavirus disease 2019 (COVID-19) trials (baricitinib, tocilizumab). However, many current applications provide limited insight due to violations of core assumptions, yielding uninterpretable results. This article reviews MR principles, assumptions, and specific challenges in ID. We highlight examples violating key assumptions, noting that MR studies using infection as an exposure are particularly prone to bias compared to using infection as an outcome. We discuss the future of MR in ID, emphasizing appropriate application to address causal questions unanswerable by other methods and capitalize on emerging opportunities where MR can provide unique insights.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
- Infection Science, North Bristol NHS Trust, Bristol, United Kingdom.
- Division of Infectious Diseases, McGill University Health Centre, Montreal, Quebec, Canada.
- Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
ORCID-Profile: Fergus Hamilton, Guillaume Butler-Laporte, George Davey Smith
Förderung
- National Institute for Health and Care Research
- Medical Research Council
Zitieren
APA
Hamilton, F., Butler-Laporte, G., & Davey Smith, G. (2025). Mendelian Randomization and Infection: Pitfalls and Promises. The Journal of Infectious Diseases, 232(3), 525-533. https://doi.org/10.1093/infdis/jiaf251
Vancouver
Hamilton F, Butler-Laporte G, Davey Smith G. Mendelian Randomization and Infection: Pitfalls and Promises. The Journal of Infectious Diseases. 2025;232(3):525-533. doi:10.1093/infdis/jiaf251
BibTeX
@article{Hamilton2025,
author = {Hamilton, Fergus and Butler-Laporte, Guillaume and Davey Smith, George},
title = {Mendelian Randomization and Infection: Pitfalls and Promises},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {3},
pages = {525--533},
doi = {10.1093/infdis/jiaf251}
}
EUVIMED